Notice2023-05476
Office of the Secretary; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 17, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 52 (Friday, March 17, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 52 (Friday, March 17, 2023)]
[Notices]
[Page 16456]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-05476]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Muscular Dystrophy
Coordinating Committee (MDCC).
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to
participate and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting.
Name of Committee: Muscular Dystrophy Coordinating Committee.
Date: April 11, 2023.
Time: 1:00 p.m. to 5:00 p.m. EDT.
Agenda: The purpose of this meeting is to bring together
committee members, representing government agencies, patient
advocacy groups, other voluntary health organizations, and patients
and their families to update one another on progress relevant to the
Action Plan for the Muscular Dystrophies and to coordinate
activities and discuss gaps and opportunities leading to better
understanding of the muscular dystrophies, advances in treatments,
and improvements in patients' and their families' lives. The agenda
for this meeting will be available on the MDCC website: <a href="https://www.mdcc.nih.gov/">https://www.mdcc.nih.gov/</a>.
Registration: To register, please go to: <a href="https://roseliassociates.zoomgov.com/webinar/register/WN_1r51-2vjR32Ol5FLjSnzlA">https://roseliassociates.zoomgov.com/webinar/register/WN_1r51-2vjR32Ol5FLjSnzlA</a>.
Webcast Live: <a href="https://videocast.nih.gov/">https://videocast.nih.gov/</a>.
Place: National Institutes of Health, Building 31, C-Wing, 6th
floor, 6C Room A&B, 31 Center St., Bethesda, MD 20892.
Contact Person: Glen Nuckolls, Ph.D., Program Director, National
Institute of Neurological Disorders and Stroke (NINDS), NIH, 6001
Executive Blvd., Rm. 2203, Bethesda, MD 20892, 301-496-5876,
<a href="/cdn-cgi/l/email-protection#d19c95929291bfb8b9ffb6bea7"><span class="__cf_email__" data-cfemail="d39e97909093bdbabbfdb4bca5">[email protected]</span></a>.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has procedures at <a href="https://www.nih.gov/about-nih/visitor-information/campus-access-security">https://www.nih.gov/about-nih/visitor-information/campus-access-security</a> for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Additional Health and Safety Guidance: Before attending a
meeting at an NIH facility, it is important that visitors review the
NIH COVID-19 Safety Plan at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx</a> for information about
requirements and procedures for entering NIH facilities, especially
when COVID-19 community levels are medium or high. In addition, the
Safer Federal Workforce website has FAQs for visitors at <a href="https://www.saferfederalworkforce.gov/faq/visitors/">https://www.saferfederalworkforce.gov/faq/visitors/</a>. Please note that if an
individual has a COVID-19 diagnosis within 10 days of the meeting,
that person must attend virtually. (For more information please read
NIH's Requirements for Persons after Exposure at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx</a> and What
Happens When Someone Tests Positive at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx</a>.) Anyone from the public can attend the open
portion of the meeting virtually via the NIH Videocasting website
(<a href="http://videocast.nih.gov">http://videocast.nih.gov</a>). Please continue checking these websites,
in addition to the committee website listed below, for the most up
to date guidance as the meeting date approaches.
More information can be found on the Muscular Dystrophy
Coordinating Committee home page: <a href="https://mdcc.nih.gov/">https://mdcc.nih.gov/</a>.
Dated: March 13, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-05476 Filed 3-16-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 17, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.